Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1963 10
1964 12
1965 10
1966 19
1967 11
1968 17
1969 8
1970 5
1971 6
1972 15
1973 14
1974 18
1975 23
1976 27
1977 13
1978 35
1979 32
1980 21
1981 39
1982 24
1983 52
1984 38
1985 68
1986 71
1987 100
1988 183
1989 214
1990 279
1991 302
1992 234
1993 326
1994 396
1995 405
1996 410
1997 461
1998 538
1999 598
2000 700
2001 704
2002 819
2003 934
2004 1008
2005 1174
2006 1433
2007 1416
2008 1263
2009 1333
2010 1326
2011 1349
2012 1411
2013 1440
2014 1529
2015 1598
2016 1506
2017 1505
2018 1443
2019 1405
2020 1517
2021 1522
2022 1419
2023 1145
2024 5

Text availability

Article attribute

Article type

Publication date

Search Results

33,084 results

Results by year

Filters applied: . Clear all
Page 1
Atherosclerosis: Known and unknown.
Fan J, Watanabe T. Fan J, et al. Pathol Int. 2022 Mar;72(3):151-160. doi: 10.1111/pin.13202. Epub 2022 Jan 25. Pathol Int. 2022. PMID: 35076127 Review.
In humans, it takes several decades until the clinical complications develop. There are many known risk factors for atherosclerosis, including hypercholesterolemia, hypertension, diabetes and smoking, which are involved in the pathogenesis of atherosclerosis; howeve …
In humans, it takes several decades until the clinical complications develop. There are many known risk factors for atherosclerosis, …
The changing landscape of atherosclerosis.
Libby P. Libby P. Nature. 2021 Apr;592(7855):524-533. doi: 10.1038/s41586-021-03392-8. Epub 2021 Apr 21. Nature. 2021. PMID: 33883728 Review.
Emerging evidence has spurred a considerable evolution of concepts relating to atherosclerosis, and has called into question many previous notions. Here I review this evidence, and discuss its implications for understanding of atherosclerosis. ...Atherosclerosis …
Emerging evidence has spurred a considerable evolution of concepts relating to atherosclerosis, and has called into question many pre …
Research Progress on the Relationship between Atherosclerosis and Inflammation.
Zhu Y, Xian X, Wang Z, Bi Y, Chen Q, Han X, Tang D, Chen R. Zhu Y, et al. Biomolecules. 2018 Aug 23;8(3):80. doi: 10.3390/biom8030080. Biomolecules. 2018. PMID: 30142970 Free PMC article. Review.
Atherosclerosis-related inflammation is mediated by proinflammatory cytokines, inflammatory signaling pathways, bioactive lipids, and adhesion molecules. This review discusses the effects of inflammation and the systemic inflammatory signaling pathway on atherosclerosis …
Atherosclerosis-related inflammation is mediated by proinflammatory cytokines, inflammatory signaling pathways, bioactive lipids, and …
The Diabetes Mellitus-Atherosclerosis Connection: The Role of Lipid and Glucose Metabolism and Chronic Inflammation.
Poznyak A, Grechko AV, Poggio P, Myasoedova VA, Alfieri V, Orekhov AN. Poznyak A, et al. Int J Mol Sci. 2020 Mar 6;21(5):1835. doi: 10.3390/ijms21051835. Int J Mol Sci. 2020. PMID: 32155866 Free PMC article. Review.
It was shown that both types of diabetes mellitus can actually induce atherosclerosis development or further accelerate its progression. Elevated glucose level, dyslipidemia, and other metabolic alterations that accompany the disease development are tightly involved in the …
It was shown that both types of diabetes mellitus can actually induce atherosclerosis development or further accelerate its progressi …
Atherosclerosis and inflammation. New therapeutic approaches.
Pedro-Botet J, Climent E, Benaiges D. Pedro-Botet J, et al. Med Clin (Barc). 2020 Sep 25;155(6):256-262. doi: 10.1016/j.medcli.2020.04.024. Epub 2020 Jun 20. Med Clin (Barc). 2020. PMID: 32571617 Review. English, Spanish.
Hence, innate and adaptive immune responses play an important role in the onset and progression of atherosclerosis. More recently, some clinical studies were designed to address the impact of anti-inflammatory intervention strategies in reducing risk of cardiovascular dise …
Hence, innate and adaptive immune responses play an important role in the onset and progression of atherosclerosis. More recently, so …
Immunity, atherosclerosis and cardiovascular disease.
Frostegård J. Frostegård J. BMC Med. 2013 May 1;11:117. doi: 10.1186/1741-7015-11-117. BMC Med. 2013. PMID: 23635324 Free PMC article. Review.
Atherosclerosis, the major cause of cardiovascular disease (CVD), is a chronic inflammatory condition with immune competent cells in lesions producing mainly pro-inflammatory cytokines. ...The potential causes of immune reactions and inflammation in atherosclerosis …
Atherosclerosis, the major cause of cardiovascular disease (CVD), is a chronic inflammatory condition with immune competent cells in …
Progress and challenges in translating the biology of atherosclerosis.
Libby P, Ridker PM, Hansson GK. Libby P, et al. Nature. 2011 May 19;473(7347):317-25. doi: 10.1038/nature10146. Nature. 2011. PMID: 21593864 Review.
Atherosclerosis is a chronic disease of the arterial wall, and a leading cause of death and loss of productive life years worldwide. ...Yet, despite these advances, we still lack definitive evidence to show that processes such as lipoprotein oxidation, inflammation and imm …
Atherosclerosis is a chronic disease of the arterial wall, and a leading cause of death and loss of productive life years worldwide. …
Lifestyle factors and high-risk atherosclerosis: Pathways and mechanisms beyond traditional risk factors.
Lechner K, von Schacky C, McKenzie AL, Worm N, Nixdorff U, Lechner B, Kränkel N, Halle M, Krauss RM, Scherr J. Lechner K, et al. Eur J Prev Cardiol. 2020 Mar;27(4):394-406. doi: 10.1177/2047487319869400. Epub 2019 Aug 13. Eur J Prev Cardiol. 2020. PMID: 31408370 Free PMC article. Review.
Collectively, low-risk lifestyle factors cause a set of phenotypic adaptations shifting tissue cross-talk from a proinflammatory milieu conducive for high-risk atherosclerosis to an anti-atherogenic milieu. The ketone body ss-hydroxybutyrate, through inhibition of the NLRP …
Collectively, low-risk lifestyle factors cause a set of phenotypic adaptations shifting tissue cross-talk from a proinflammatory milieu cond …
Clinical Advances in Immunonutrition and Atherosclerosis: A Review.
Ruiz-León AM, Lapuente M, Estruch R, Casas R. Ruiz-León AM, et al. Front Immunol. 2019 Apr 24;10:837. doi: 10.3389/fimmu.2019.00837. eCollection 2019. Front Immunol. 2019. PMID: 31068933 Free PMC article. Review.
Atherosclerosis is a chronic low-grade inflammatory disease that affects large and medium-sized arteries and is considered to be a major underlying cause of cardiovascular disease (CVD). The high risk of mortality by atherosclerosis has led to the development of new …
Atherosclerosis is a chronic low-grade inflammatory disease that affects large and medium-sized arteries and is considered to be a ma …
Nutrition and Atherosclerosis.
Torres N, Guevara-Cruz M, Velázquez-Villegas LA, Tovar AR. Torres N, et al. Arch Med Res. 2015 Jul;46(5):408-26. doi: 10.1016/j.arcmed.2015.05.010. Epub 2015 May 29. Arch Med Res. 2015. PMID: 26031780 Review.
Cardiovascular disease (CVD) is a universal problem in modern society. Atherosclerosis is the leading cause of CVD resulting in high rate of mortality in the population. ...It is important to establish that the first strategy to treat atherosclerosis is to modify li …
Cardiovascular disease (CVD) is a universal problem in modern society. Atherosclerosis is the leading cause of CVD resulting in high …
33,084 results
You have reached the last available page of results. Please see the User Guide for more information.